scispace - formally typeset
F

Fu-Tien Chiang

Researcher at Fu Jen Catholic University

Publications -  260
Citations -  8268

Fu-Tien Chiang is an academic researcher from Fu Jen Catholic University. The author has contributed to research in topics: Coronary artery disease & Population. The author has an hindex of 43, co-authored 253 publications receiving 7570 citations. Previous affiliations of Fu-Tien Chiang include National Taiwan University & Memorial Hospital of South Bend.

Papers
More filters
Journal ArticleDOI

Effect of valsartan on the incidence of diabetes and cardiovascular events.

John J.V. McMurray, +53 more
TL;DR: Among patients with impaired glucose tolerance and cardiovascular disease or risk factors, the use of valsartan for 5 years, along with lifestyle modification, led to a relative reduction of 14% in the incidence of diabetes but did not reduce the rate of cardiovascular events.
Journal ArticleDOI

A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility

TL;DR: A comprehensive and flexible framework for detecting and interpreting gene-gene interactions that utilizes advances in information theory for selecting interesting single-nucleotide polymorphisms (SNPs), MDR for constructive induction, machine learning methods for classification, and finally graphical models for interpretation is described.
Journal ArticleDOI

Effect of nateglinide on the incidence of diabetes and cardiovascular events

Rury R. Holman, +56 more
TL;DR: Among persons with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors, assignment to nateglinide for 5 years did not reduce the incidence of diabetes or the coprimary composite cardiovascular outcomes.
Journal ArticleDOI

Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation

TL;DR: This study demonstrates the association of RAS gene polymorphisms with nonfamilial structural AF and may provide the rationale for clinical trials to investigate the use of ACE inhibitor or angiotensin II antagonist in the treatment of structural AF.
Journal ArticleDOI

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Menno V. Huisman, +1027 more
TL;DR: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombinotic t...